Genitourinary Cancer,RCC (Renal Cell Carcinoma) Pembrolizumab vs. Placebo in ccRCC: KEYNOTE-564 Jan 30, 2024
Genitourinary Cancer,Lung Cancer,NSCLC (Non-Small Cell Lung Cancer),RCC (Renal Cell Carcinoma) Casdozo & Pembro Efficacy in Refractory NSCLC Treatment Jan 22, 2024
Bladder Cancer,Genitourinary Cancer MIBC: TMT With PD-1 Inhibitor and Hypo-Fractionated Radiation Jan 22, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Implications of CD8+ T Cells in RCC: Insights on IO Resistance Jan 15, 2024
Bladder Cancer,Genitourinary Cancer EG-70: Promising Safety & Efficacy in High-Risk Bladder Cancer Jan 09, 2024
Bladder Cancer,Genitourinary Cancer Subcutaneous Fat Area as Parastomal Hernia Risk: PUBMIC Trial Data Jan 08, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Pembrolizumab Boosts DFS in RCC Across Risk Groups Jan 05, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Cx26: A Potential Biomarker and Therapeutic Target in ccRCC Jan 04, 2024
